Labnovation Technologies Inc

Founded in Shenzhen in 2001, Labnovation specializes in HbA1c platforms and compatible hematology reagents. It pioneered dual-platform HbA1c technology (HPLC + boronate affinity), delivering reliable results for diabetes management across diverse healthcare settings. With exports to over 100 countries, quality is why clinicians choose us. Since 2024, integrated with BioGerm Group, we now focus on advancing both infectious disease diagnostics and chronic disease management for comprehensive healthcare solutions.